WAYNE STATE UNIVERSITY
LOS ANGELES, Texas
Total Received
$292.1M
Total Awards
174
State
Texas
Last Updated
Mar 20, 2026
Yearly Funding Trend
$253.6M24
$34.5M25
$4.1M26
Top 50 Awards to WAYNE STATE UNIVERSITY
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P01AI152999_075 DYNAMICS OF COLONIZATION AND INFECTION BY MULTIDRUG-RESISTANT PATHOGENS IN IMMUNOCOMPROMISED AND CRITICALLY ILL PATIENTS (DYNAMITE) - ABSTRACT - OVERALL DYNAMICS OF COLONIZATION A… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $12,038,412 |
ASST_NON_U54CA210181_075 CENTER FOR IMMUNOTHERAPEUTIC TRANSPORT ONCOPHYSICS - OVERALL – SUMMARY THE US FOOD AND DRUG ADMINISTRATION RECENTLY APPROVED SEVERAL IMMUNOTHERAPIES FOR THE TREATMENT OF METASTATI… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | HOUSTON, TX-09 | 2024 | $9,036,271 |
ASST_NON_U54CA274375_075 THE STROMAL MICROENVIRONMENT AS A CO-ORGANIZER OF BLADDER CARCINOGENESIS AND PROGRESSION - OVERALL PROJECT SUMMARY BLADDER CANCER (BC) IS THE SECOND MOST COMMON UROLOGIC MALIGNAN… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | TX-90 | 2024 | $6,871,892 |
ASST_NON_U01NS104326_075 CLINICAL TRIAL READINESS FOR SCA1 AND SCA3 - SPINOCEREBELLAR ATAXIA TYPES 1 (SCA1) AND 3 (SCA3) ARE RARE, INHERITED NEURODEGENERATIVE DISORDERS THAT RELENTLESSLY PROGRESS TO TOTAL… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | HOUSTON, TX-90 | 2024 | $6,148,541 |
ASST_NON_R01CA175397_075 DISTINCT TUMOR AND METASTATIC COLLAGEN MICROENVIRONMENTS: DIVERGENT TARGETING APPROACHES - PROJECT SUMMARY METASTATIC PROGRESSION OF THE PRIMARY TUMOR ACCOUNTS FOR THE MAJORITY OF… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | CA-90 | 2024 | $4,794,682 |
ASST_NON_R01AI080779_075 MODULATION OF INNATE IMMUNE CELLS TO CREATE TRANSPLANT TOLERANCE - PROJECT SUMMARY MACROPHAGES AS A KEY CELL TYPE IN THE INNATE IMMUNE SYSTEM ARE INVOLVED IN A WIDE SPECTRUM OF AL… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $4,738,818 |
ASST_NON_R01DE021863_075 OUTCOME-DRIVEN APPROACH TO MINIMIZE THE RISKS OF FACIAL DISTORTION FOLLOWING CMF SURGERY - ABSTRACT: OUR MAIN CLINICAL MOTIVATION OF THIS PROJECT IS TO PROVIDE PERSONALIZED PRECI… | Department of Health and Human Services National Institutes of Health | 93.121 ORAL DISEASES AND DISORDERS RESEARCH | HOUSTON, TX-90 | 2024 | $4,528,807 |
ASST_NON_R01AI165372_075 ULTRA-LONG ACTING TRANSCUTANEOUSLY REFILLABLE ISLATRAVIR NANOFLUIDIC IMPLANT FOR HIV PRE-EXPOSURE - MODIFIED PROJECT SUMMARY/ABSTRACT SECTION LONG-ACTING (LA) PRE-EXPOSURE PROPHY… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $4,459,174 |
ASST_NON_R01HL103827_075 TARGETING NOTCH2 IN HEMATOPOIETIC CELL THERAPY - R01HL103827-06A1 RESUBMISSION (ZHOU, LAN) 10.22.2018 ABSTRACT HEMATOPOIETIC STEM CELL (HSC) TRANSPLANTATION IS THE ONLY CURATIVE O… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TX-90 | 2024 | $4,299,712 |
ASST_NON_R01DE022676_075 A NOVEL IMAGING ANALYSIS PLATFORM FOR PATIENTS WITH CRANIOMAXILLOFACIAL DEFORMITIES - DESCRIPTION (PROVIDED BY APPLICANT): OUR ULTIMATE GOAL IS TO IMPROVE OUR ABILITY TO CREATE AN… | Department of Health and Human Services National Institutes of Health | 93.121 ORAL DISEASES AND DISORDERS RESEARCH | HOUSTON, TX-90 | 2024 | $3,924,782 |
ASST_NON_R01CA163910_075 TARGETING ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA - PROJECT SUMMARY/ABSTRACT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IS AN INCURABLE B CELL MALIGNANCY THAT REPRESENTS… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | TX-90 | 2025 | $3,838,579 |
ASST_NON_R01EY026156_075 THE IMPACT OF SLEEP ON NETWORK CODING AND PERCEPTUAL PERFORMANCE - PROJECT SUMMARY A CRITICAL ISSUE FOR UNDERSTANDING SLEEP FUNCTION IS WHETHER AND HOW IT IMPACTS THE ACCURACY OF… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | TX-90 | 2024 | $3,832,179 |
ASST_NON_R01AI161015_075 NOVEL STEM CELL IMMUNOTHERAPY FOR MDR-TUBERCULOSIS - ABSTRACT TUBERCULOSIS (TB) KILLS AROUND 2 MILLION PEOPLE EACH YEAR AND IS A MAJOR CAUSE OF MORTALITY FROM A SINGLE INFECTIOUS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $3,825,440 |
ASST_NON_R01AI106200_075 CONTROL OF DYSFUNCTIONAL TREGS - PROJECT SUMMARY REJECTION REMAINS A MAJOR HURDLE TO LONG LASTING TRANSPLANT SURVIVAL AND WE ASPIRE TO UNCOVER THE FUNDAMENTAL MECHANISMS THAT HIND… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $3,731,435 |
ASST_NON_R01AI122070_075 A NEONATAL MONKEY MODEL OF TUBERCULOSIS VACCINATION - ABSTRACT TUBERCULOSIS DUE TO MYCOBACTERIUM TUBERCULOSIS (MTB) IS THE LEADING CAUSE OF MORTALITY DUE TO INFECTIONS TODAY WITH… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $3,600,401 |
ASST_NON_RF1NS118584_075 AGE-RELATED TDP-43 NEUROPATHOLOGY: USING DISEASE-DRIVING MECHANISMS TO GUIDE CLASSIFICATION - LIMBIC-PREDOMINANT AGE-RELATED TDP-43 ENCEPHALOPATHY NEUROPATHOLOGIC CHANGE (LATE-NC)… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | HOUSTON, TX-90 | 2024 | $3,179,031 |
ASST_NON_R01HL168277_075 CARDIAC AUTONOMIC ACTIVATION IN ATRIAL FIBRILLATION TRIGGERS AND SUBSTRATE - PROJECT SUMMARY/ABSTRACT ATRIAL FIBRILLATION (AF) IS THE MOST COMMON SUSTAINED ADULT ARRHYTHMIA, ASSOC… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | HOUSTON, TX-09 | 2024 | $3,155,755 |
ASST_NON_R01AG071496_075 SYSTEMATIC MODELING AND PREDICTION OF CELL-TYPE-SPECIFIC AND SPATIOTEMPORAL CROSSTALK PATHWAYS IN ALZHEIMER'S DISEASE - ABSTRACT ALZHEIMER’S DISEASE (AD) AFFECTS MORE THAN 50 MILL… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | HOUSTON, TX-90 | 2024 | $3,147,393 |
ASST_NON_R01CA208648_075 CHEMOPREVENTION OF LUNG CANCER WITH MITOCHONDRIA-TARGETED HONOKIOL - PROJECT SUMMARY: NON-SMALL-CELL LUNG CANCERS (NSCLCS) ARE THE MOST COMMON LUNG CANCERS, ACCOUNTING FOR 85% OF… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | HOUSTON, TX-90 | 2024 | $3,145,278 |
ASST_NON_R01DK133610_075 VASCULARIZED NICHE WITH LOCAL IMMUNOSUPPRESSION FOR CELL REPLACEMENT FOR TYPE 1 DIABETES - CELL ENCAPSULATION TECHNOLOGIES ARE POISED TO IMPROVE CONVENTIONAL ISLET TRANSPLANTATION… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | HOUSTON, TX-90 | 2024 | $3,096,729 |
ASST_NON_R01CA271682_075 VALIDATION OF A NOVEL 3D CULTURE PLATFORM FOR TNBC TREATMENT SELECTION - PROJECT SUMMARY THE GOAL OF THIS ACADEMIC [HOUSTON METHODIST RESEARCH INSTITUTE (HMRI) AND MD ANDERSON CAN… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | HOUSTON, TX-90 | 2024 | $3,027,149 |
ASST_NON_R01HL163535_075 HUMAN ATHEROGENESIS WITH UNDERLYING DYSFUNCTIONAL HDL-FREE CHOLESTEROL - ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) AND PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C) ARE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | HOUSTON, TX-09 | 2024 | $2,960,806 |
ASST_NON_R01HL171150_075 SUDDEN DEATH RISK ASSESSMENT AND MECHANISTIC INSIGHTS IN ARRHYTHMIC MITRAL VALVE PROLAPSE USING CARDIAC MRI AND CIRCULATING PROTEOMIC BIOMARKERS - PROJECT SUMMARY: MITRAL VALVE PR… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | HOUSTON, TX-09 | 2024 | $2,960,139 |
ASST_NON_R01AI134637_075 THE LIAFSR SYSTEM AND ANTIMICROBIAL PEPTIDE RESISTANCE IN ENTEROCOCCI - ABSTRACT THE EMERGENCE OF ANTIBIOTIC-RESISTANT BACTERIA IS ONE OF THE GREATEST THREATS TO HUMAN HEALTH IN T… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $2,888,511 |
ASST_NON_R01AI162748_075 MOLECULAR MECHANISM OF VIRULENCE REGULATION IN STREPTOCOCCUS PYOGENES - PATHOGENIC BACTERIA SURVIVE IN COMPLEX AND HOSTILE ENVIRONMENTS IN THE HOST. SEVERAL HOST- AND MICROBIOTA-D… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $2,818,660 |
ASST_NON_R01AG057635_075 SYSTEMATIC ALZHEIMER'S DISEASE DRUG REPOSITIONING (SMART) BASED ON BIOINFORMATICS-GUIDED PHENOTYPE SCREENING AND IMAGE-OMICS - PROJECT SUMMARY GIVEN THE COMPLEXITY OF ALZHEIMER'S… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | HOUSTON, TX-90 | 2025 | $2,787,212 |
ASST_NON_R01DK132104_075 VASCULARIZED ISLET TRANSPLANTATION NICHE WITH LOCAL IMMUNOSUPPRESSION FOR THE TREATMENT OF TYPE 1 DIABETES - CELL ENCAPSULATION TECHNOLOGIES ARE POISED TO IMPROVE CONVENTIONAL ISL… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | HOUSTON, TX-90 | 2024 | $2,778,087 |
ASST_NON_R01AI184394_075 REGULATION OF INNATE IMMUNITY BY SELF-ADJUVATED MRNA VACCINES - ABSTRACT MYCOBACTERIUM TUBERCULOSIS (MTB), THE CAUSATIVE AGENT OF PULMONARY AND NON-PULMONARY TUBERCULOSIS (TB), KI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $2,710,680 |
ASST_NON_R01HL148338_075 REVERSAL OF HEART FAILURE: ROLE OF VASCULAR RECOVERY - PROJECT SUMMARY HEART FAILURE IS A MAJOR CAUSE OF MORBIDITY AND MORTALITY WORLDWIDE, CURRENTLY AFFECTING AN ESTIMATED 6.5 MI… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | HOUSTON, TX-90 | 2025 | $2,661,080 |
ASST_NON_R01CA223804_075 TRANSFER APPLICATION - R01 CA223804 - CHEMOIMMUNOPREVENTION OF EGFR-DRIVEN NON-SMALL CELL LUNG CANCER - PROJECT SUMMARY LUNG CANCER IS THE LEADING CAUSE OF CANCER MORTALITY WORLDW… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | HOUSTON, TX-90 | 2025 | $2,583,342 |
ASST_NON_R01CA205633_075 INHIBITION OF ORAL TUMORIGENESIS BY ANTITUMOR B - PROJECT SUMMARY: ANTITUMOR B (ATB), ALSO KNOWN AS ZENG SHENG PING, IS A TABLET MADE ACCORDING TO MODERN GMP STANDARDS. IT CONTAIN… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | HOUSTON, TX-90 | 2024 | $2,567,480 |
ASST_NON_R01NS119587_075 HARNESSING NEUROPLASTICITY OF POSTURAL SENSORIMOTOR NETWORKS USING NON-INVASIVE SPINAL NEUROMODULATION TO MAXIMIZE FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY - ABSTRACT TRANSCUT… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | HOUSTON, TX-90 | 2024 | $2,544,362 |
ASST_NON_R01AI184551_075 SIRTUIN -DEPENDENT REGULATION OF TUBERCULOSIS AND HIV INTERACTIONS IN MACROPHAGES - ABSTRACT TUBERCULOSIS CONTINUES TO KILL ABOUT 1 MILLION PEOPLE INCLUDING CHILDREN EACH YEAR WIT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-09 | 2024 | $2,534,348 |
ASST_NON_R01AI167659_075 LONG-ACTING MULTI PREVENTION IMPLANT FOR 2-YEAR CONTRACEPTION AND HIV PREP - PROJECT SUMMARY/ABSTRACT MATERNAL MORTALITY AND AIDS ARE AMONG THE LEADING CAUSES OF DEATH IN REPRODUC… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-09 | 2024 | $2,464,240 |
ASST_NON_U01CA253553_075 SPATIOTEMPORAL MODELING OF CANCER-NICHE INTERACTIONS IN BREAST CANCER BONE METASTASIS - ABSTRACT ABOUT 20-40% OF BREAST CANCER PATIENTS DEVELOP METASTASIS TO THE BONE, YEARS TO EV… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | HOUSTON, TX-90 | 2024 | $2,427,542 |
ASST_NON_R01AI175699_075 DEEP LEARNING BASED PHARMACOKINETIC MODEL FOR VANCOMYCIN - ABSTRACT: (30 LINES) VANCOMYCIN IS ONE OF THE MOST COMMONLY USED ANTIMICROBIAL DRUGS IN INPATIENT SETTINGS. NATIONAL GUI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2024 | $2,398,639 |
ASST_NON_R01AI176558_075 REGULATION OF CELL DEATH IN HIV RESERVOIRS - ABSTRACT: THE COMBINATIONAL ANTIRETROVIRAL THERAPY IS EFFECTIVE IN SUPPRESSING HIV-1 REPLICATION. HOWEVER, LATENT HIV RESERVOIRS CANNO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-09 | 2024 | $2,372,740 |
ASST_NON_R01DE027251_075 LEARNING-BASED APPROACH FOR PERSONALIZED CRANIOMAXILLOFACIAL SURGICAL PLANNING - ABSTRACT: OUR MAIN CLINICAL OBJECTIVE FOR THIS PROJECT IS TO PROVIDE PERSONALIZED PRECISION CARE T… | Department of Health and Human Services National Institutes of Health | 93.121 ORAL DISEASES AND DISORDERS RESEARCH | HOUSTON, TX-90 | 2024 | $2,326,604 |
ASST_NON_R01CA222959_075 MECHANISM OF INTRATUMORAL TRANSPORT OF PARTICULATE DRUGS - THE TUMOR VASCULATURE IS GENERALLY CONSIDERED AS LEAKY, AND THUS ALLOWS ACCUMULATION OF BIG MOLECULES AND PARTICLES WITH… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | HOUSTON, TX-90 | 2024 | $2,311,448 |
ASST_NON_R01CA208703_075 MODULATION OF TUMOR INFLAMMATORY FACTOR FOR IMMUNE THERAPY - THE STUDY OF TUMOR-ASSOCIATED INFLAMMATORY FACTORS IS ESSENTIAL FOR DETERMINING THE RELATIONSHIP BETWEEN THE TUMOR MIC… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | HOUSTON, TX-90 | 2024 | $2,301,500 |
ASST_NON_R01CA268340_075 XBP1 INHIBITION AND STING ACTIVATION FOR THE TREATMENT OF CANCER - PROJECT SUMMARY THIS RESEARCH PROJECT FOCUSES ON TESTING AND FINDING CURES FOR PATIENTS DIAGNOSED WITH CHRONIC L… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | HOUSTON, TX-90 | 2024 | $2,273,099 |
ASST_NON_R01CA238727_075 SYSTEMATIC IDENTIFICATION OF ASTROCYTE-TUMOR CROSSTALK REGULATING BRAIN METASTATIC TUMORS - AS TREATMENT OUTCOMES OF PRIMARY OR SYSTEMIC CANCER SITES IMPROVE, THE CLINICAL IMPORTA… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | HOUSTON, TX-90 | 2024 | $2,251,274 |
ASST_NON_R01CA204191_075 LILRB MODULATES TUMOR MICROENVIRONMENT AND PROMOTES TUMOR PROGRESSION - PROJECT SUMMARY MYELOID CELLS, INCLUDING MONOCYTES AND MACROPHAGES, ARE CLASSICALLY ACTIVATED TO CLEAR PATH… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | TX-90 | 2024 | $2,135,883 |
ASST_NON_R01AI129906_075 T CELL FATE DECISIONS AND TRANSPLANT OUTCOMES - PROJECT SUMMARY REJECTION REMAINS A MAJOR HURDLE TO LONG-LASTING TRANSPLANT SURVIVAL. FROM A CLINICAL STANDPOINT CURRENT IMMUNOSUPP… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $2,132,319 |
ASST_NON_U01CA244107_075 BIOPHYSICAL ROLES OF PRE-METASTATIC NICHE EVOLUTION ON TRANSPORT OF CIRCULATING TUMOR CELLS - METASTATIC DISEASE IS RESISTANT TO CURRENT THERAPIES AND REMAINS THE PRIMARY CAUSE OF… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | HOUSTON, TX-90 | 2024 | $2,102,910 |
ASST_NON_R01CA239255_075 ROLE OF TUMOR MICROENVIRONMENT-DERIVED CHOLESTEROL IN CD8+ T-CELL EXHAUSTION - PROJECT SUMMARY RECENTLY WE DISCOVERED THAT CHOLESTEROL METABOLICALLY REPROGRAMS TUMOR-INFILTRATING… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | HOUSTON, TX-90 | 2026 | $2,099,851 |
ASST_NON_R01CA222064_075 HES1-LOSS PROMOTES DYSREGULATION OF EPITHELIAL HOMEOSTASIS AND INFLAMMATION IN A SERRATED ADENOCARCINOMA MODEL - ABSTRACT DISTINCT FROM THE CONVENTIONAL ADENOMA–CARCINOMA PATHWAY,… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | TX-90 | 2024 | $2,049,973 |
ASST_NON_R01HL134740_075 A NOVEL ROLE FOR MAGI1 IN REGULATING NON-CANONICAL LATS SIGNALING AND ATHEROSCLEROTIC PLAQUE FORMATION - PROJECT SUMMARY PRO-ATHEROGENIC STIMULI SUCH AS INFLAMMATORY CYTOKINES AND… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | HOUSTON, TX-90 | 2024 | $2,027,225 |
ASST_NON_R01AI146257_075 GUT MICROBIOME COMMUNICATION WITH THE BONE MARROW REGULATES INTESTINAL INFLAMMATION. - PROJECT SUMMARY SIGNIFICANCE: THERE IS AN URGENT NEED FOR NOVEL APPROACHES TO TREAT OR PREVE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | HOUSTON, TX-09 | 2024 | $2,018,750 |
ASST_NON_RF1NS112719_075 DEFINING THE ALTERED FUS-PARP-1-DNA LIGASE III AXIS AND ITS IMPLICATIONS TO NUCLEAR AND MITOCHONDRIAL GENOME DAMAGE RESPONSE IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND FRONTOTEMPO… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | HOUSTON, TX-90 | 2025 | $2,018,750 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$71.9M
93.396 — CANCER BIOLOGY RESEARCH$47.8M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$30.5M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$24.0M
93.395 — CANCER TREATMENT RESEARCH$20.5M
93.866 — AGING RESEARCH$16.0M
93.397 — CANCER CENTERS SUPPORT GRANTS$15.9M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$12.1M
93.121 — ORAL DISEASES AND DISORDERS RESEARCH$10.8M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$8.4M
Source: USAspending.gov · All Recipients · Texas